Copyright
©The Author(s) 2015.
World J Gastroenterol. May 21, 2015; 21(19): 5979-5984
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.5979
Published online May 21, 2015. doi: 10.3748/wjg.v21.i19.5979
Table 2 Patient characteristics
| Characteristic | n (%) |
| Sex | |
| Male | 10 (83) |
| Female | 2 (17) |
| Median age | 69 (range 44-77) |
| Primary lesion | |
| Intrahepatic | 2 (17) |
| Extrahepatic | 3 (25) |
| Gallbladder | 7 (58) |
| Ampulla of vater | 0 (0) |
| Disease status | |
| Unresectable | 12 (100) |
| Recurrent | 0 (0) |
| Performance status (0/1) | 12/0 |
| Biliary drainage | 6 (50) |
| Median CEA (ng/mL) | 3 (range 1.1-33.4) |
| Median CA19-9 (U/mL) | 156.5 (range 1.0- > 10000) |
- Citation: Watanabe A, Kida M, Miyazawa S, Iwai T, Okuwaki K, Kaneko T, Yamauchi H, Takezawa M, Imaizumi H, Koizumi W. Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer. World J Gastroenterol 2015; 21(19): 5979-5984
- URL: https://www.wjgnet.com/1007-9327/full/v21/i19/5979.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i19.5979